305 related articles for article (PubMed ID: 27777436)
1. A Multicenter, Prospective, Randomized Controlled Trial Evaluating the Efficacy of Rectal Diclofenac and Sublingual Nitroglycerin as a Combined Prophylactic Treatment for Post-ERCP Pancreatitis.
Tomoda T; Kato H; Mizukawa S; Muro S; Akimoto Y; Uchida D; Matsumoto K; Yamamoto N; Horiguchi S; Tsutsumi K; Okada H
Acta Med Okayama; 2016 Octoaber; 70(5):405-408. PubMed ID: 27777436
[TBL] [Abstract][Full Text] [Related]
2. Combination of Diclofenac and Sublingual Nitrates Is Superior to Diclofenac Alone in Preventing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography.
Tomoda T; Kato H; Ueki T; Akimoto Y; Hata H; Fujii M; Harada R; Ogawa T; Wato M; Takatani M; Matsubara M; Kawai Y; Okada H
Gastroenterology; 2019 May; 156(6):1753-1760.e1. PubMed ID: 30772342
[TBL] [Abstract][Full Text] [Related]
3. A Multicenter, Prospective, Randomized Controlled Trial Evaluating the Efficacy of Rectal Diclofenac and Sublingual Nitrate as a Combined Prophylactic Treatment for Post-ERCP Pancreatitis.
Tomoda T; Kato H; Mizukawa S; Muro S; Akimoto Y; Uchida D; Matsumoto K; Yamamoto N; Horiguchi S; Tsutsumi K; Okada H
Acta Med Okayama; 2017 Aug; 71(4):357-362. PubMed ID: 28824193
[TBL] [Abstract][Full Text] [Related]
4. Rectal nonsteroidal anti-inflammatory drugs administration is effective for the prevention of post-ERCP pancreatitis: An updated meta-analysis of randomized controlled trials.
Yang C; Zhao Y; Li W; Zhu S; Yang H; Zhang Y; Liu X; Peng N; Fan P; Jin X
Pancreatology; 2017; 17(5):681-688. PubMed ID: 28734720
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Combined Management with Nonsteroidal Anti-inflammatory Drugs for Prevention of Pancreatitis After Endoscopic Retrograde Cholangiography: a Bayesian Network Meta-analysis.
Du F; Zhang Y; Yang X; Zhang L; Yuan W; Fan H; Ren L
J Gastrointest Surg; 2022 Sep; 26(9):1982-1997. PubMed ID: 35680777
[TBL] [Abstract][Full Text] [Related]
6. What is impact of nonsteroidal anti-inflammatory drugs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials.
Lyu Y; Cheng Y; Wang B; Xu Y; Du W
BMC Gastroenterol; 2018 Jul; 18(1):106. PubMed ID: 29973142
[TBL] [Abstract][Full Text] [Related]
7. A meta-analysis on the role of rectal diclofenac and indomethacin in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.
Sethi S; Sethi N; Wadhwa V; Garud S; Brown A
Pancreas; 2014 Mar; 43(2):190-7. PubMed ID: 24518496
[TBL] [Abstract][Full Text] [Related]
8. Rectal Diclofenac administration for prevention of post-Endoscopic Retrograde Cholangio-Pancreatography (ERCP) acute pancreatitis. Randomized prospective study.
Geraci G; Palumbo VD; D'Orazio B; Maffongelli A; Fazzotta S; Lo Monte AI
Clin Ter; 2019; 170(5):e332-e336. PubMed ID: 31612188
[TBL] [Abstract][Full Text] [Related]
9. Diclofenac sodium versus ceftazidime for preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a prospective, randomized, controlled trial.
Hauser G; Blažević I; Salkić N; Poropat G; Giljača V; Bulić Z; Štimac D
Surg Endosc; 2017 Feb; 31(2):602-610. PubMed ID: 27317032
[TBL] [Abstract][Full Text] [Related]
10. Can Rectal Diclofenac Prevent Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis?
Lua GW; Muthukaruppan R; Menon J
Dig Dis Sci; 2015 Oct; 60(10):3118-23. PubMed ID: 25757446
[TBL] [Abstract][Full Text] [Related]
11. Low-dose rectal diclofenac does not prevent post-ERCP pancreatitis in low- or high-risk patients.
Katoh T; Kawashima K; Fukuba N; Masuda S; Kobatake H; Masaki K; Araki Y; Kawano K; Nishi K; Takenaka M; Ishihara S; Kinoshita Y
J Gastroenterol Hepatol; 2020 Jul; 35(7):1247-1253. PubMed ID: 31788849
[TBL] [Abstract][Full Text] [Related]
12. Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis with a combination of pharmacological agents based on rectal non-steroidal anti-inflammatory drugs: A systematic review and network meta-analysis.
Oh HC; Kang H; Park TY; Choi GJ; Lehman GA
J Gastroenterol Hepatol; 2021 Jun; 36(6):1403-1413. PubMed ID: 33068012
[TBL] [Abstract][Full Text] [Related]
13. The Effectiveness of the Rectal Administration of Low-dose Diclofenac for the Prevention of Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis.
Okuno M; Shiroko J; Taguchi D; Yamaguchi K; Takada J; Imai S; Sato H; Thanabashi S
Intern Med; 2018 Aug; 57(16):2289-2294. PubMed ID: 29607957
[TBL] [Abstract][Full Text] [Related]
14. Aggressive fluid hydration plus non-steroidal anti-inflammatory drugs versus non-steroidal anti-inflammatory drugs alone for post-endoscopic retrograde cholangiopancreatography pancreatitis (FLUYT): a multicentre, open-label, randomised, controlled trial.
Sperna Weiland CJ; Smeets XJNM; Kievit W; Verdonk RC; Poen AC; Bhalla A; Venneman NG; Witteman BJM; da Costa DW; van Eijck BC; Schwartz MP; Römkens TEH; Vrolijk JM; Hadithi M; Voorburg AMCJ; Baak LC; Thijs WJ; van Wanrooij RL; Tan ACITL; Seerden TCJ; Keulemans YCA; de Wijkerslooth TR; van de Vrie W; van der Schaar P; van Dijk SM; Hallensleben NDL; Sperna Weiland RL; Timmerhuis HC; Umans DS; van Hooft JE; van Goor H; van Santvoort HC; Besselink MG; Bruno MJ; Fockens P; Drenth JPH; van Geenen EJM;
Lancet Gastroenterol Hepatol; 2021 May; 6(5):350-358. PubMed ID: 33740415
[TBL] [Abstract][Full Text] [Related]
15. Combination of diclofenac plus somatostatin in the prevention of post-ERCP pancreatitis: a randomized, double-blind, placebo-controlled trial.
Katsinelos P; Fasoulas K; Paroutoglou G; Chatzimavroudis G; Beltsis A; Terzoudis S; Katsinelos T; Dimou E; Zavos C; Kaltsa A; Kountouras J
Endoscopy; 2012 Jan; 44(1):53-9. PubMed ID: 22198776
[TBL] [Abstract][Full Text] [Related]
16. Low-dose rectal diclofenac for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized controlled trial.
Otsuka T; Kawazoe S; Nakashita S; Kamachi S; Oeda S; Sumida C; Akiyama T; Ario K; Fujimoto M; Tabuchi M; Noda T
J Gastroenterol; 2012 Aug; 47(8):912-7. PubMed ID: 22350703
[TBL] [Abstract][Full Text] [Related]
17. Fluid hydration to prevent post-ERCP pancreatitis in average- to high-risk patients receiving prophylactic rectal NSAIDs (FLUYT trial): study protocol for a randomized controlled trial.
Smeets XJNM; da Costa DW; Fockens P; Mulder CJJ; Timmer R; Kievit W; Zegers M; Bruno MJ; Besselink MGH; Vleggaar FP; van der Hulst RWM; Poen AC; Heine GDN; Venneman NG; Kolkman JJ; Baak LC; Römkens TEH; van Dijk SM; Hallensleben NDL; van de Vrie W; Seerden TCJ; Tan ACITL; Voorburg AMCJ; Poley JW; Witteman BJ; Bhalla A; Hadithi M; Thijs WJ; Schwartz MP; Vrolijk JM; Verdonk RC; van Delft F; Keulemans Y; van Goor H; Drenth JPH; van Geenen EJM;
Trials; 2018 Apr; 19(1):207. PubMed ID: 29606135
[TBL] [Abstract][Full Text] [Related]
18. Indomethacin and diclofenac in the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis of prospective controlled trials.
Patai Á; Solymosi N; Mohácsi L; Patai ÁV
Gastrointest Endosc; 2017 Jun; 85(6):1144-1156.e1. PubMed ID: 28167118
[TBL] [Abstract][Full Text] [Related]
19. Intramuscular diclofenac for the prevention of post-ERCP pancreatitis: a randomized trial.
Park SW; Chung MJ; Oh TG; Park JY; Bang S; Park SW; Song SY
Endoscopy; 2015 Jan; 47(1):33-9. PubMed ID: 25409167
[TBL] [Abstract][Full Text] [Related]
20. A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis.
Elmunzer BJ; Waljee AK; Elta GH; Taylor JR; Fehmi SM; Higgins PD
Gut; 2008 Sep; 57(9):1262-7. PubMed ID: 18375470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
